PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $477,603 | -16.8% | 216,110 | -4.4% | 0.00% | – |
| Q1 2023 | $574,065 | -32.1% | 226,010 | -50.0% | 0.00% | – |
| Q4 2022 | $845,278 | +58.0% | 452,020 | +117.2% | 0.00% | – |
| Q3 2022 | $535,000 | +28.6% | 208,110 | -3.4% | 0.00% | – |
| Q2 2022 | $416,000 | -83.0% | 215,510 | -73.9% | 0.00% | – |
| Q1 2022 | $2,449,000 | -29.1% | 824,540 | +7.2% | 0.00% | – |
| Q4 2021 | $3,455,000 | -6.3% | 769,446 | +1.5% | 0.00% | – |
| Q3 2021 | $3,686,000 | -27.9% | 758,435 | +1.2% | 0.00% | – |
| Q2 2021 | $5,112,000 | +4.9% | 749,601 | +8.7% | 0.00% | – |
| Q1 2021 | $4,871,000 | +9.8% | 689,881 | -2.7% | 0.00% | – |
| Q4 2020 | $4,436,000 | +18.5% | 708,689 | +2.4% | 0.00% | – |
| Q3 2020 | $3,742,000 | +10.9% | 691,766 | +7.0% | 0.00% | – |
| Q2 2020 | $3,375,000 | +64.2% | 646,633 | -0.9% | 0.00% | – |
| Q1 2020 | $2,056,000 | -24.9% | 652,558 | -3.9% | 0.00% | – |
| Q4 2019 | $2,737,000 | -6.0% | 679,099 | +0.8% | 0.00% | – |
| Q3 2019 | $2,911,000 | +13.6% | 673,779 | +4.9% | 0.00% | – |
| Q2 2019 | $2,563,000 | -18.0% | 642,253 | +10.1% | 0.00% | – |
| Q1 2019 | $3,127,000 | +5.6% | 583,443 | +1.1% | 0.00% | – |
| Q4 2018 | $2,960,000 | -47.3% | 576,992 | -0.3% | 0.00% | – |
| Q3 2018 | $5,620,000 | +6.4% | 578,919 | +11.8% | 0.00% | – |
| Q2 2018 | $5,283,000 | -35.2% | 517,943 | -17.4% | 0.00% | -100.0% |
| Q1 2018 | $8,153,000 | -21.6% | 627,071 | +7.9% | 0.00% | 0.0% |
| Q4 2017 | $10,404,000 | -29.6% | 581,209 | -1.3% | 0.00% | 0.0% |
| Q3 2017 | $14,786,000 | -0.4% | 589,051 | -4.4% | 0.00% | 0.0% |
| Q2 2017 | $14,850,000 | +165.7% | 616,112 | +112.3% | 0.00% | – |
| Q1 2017 | $5,589,000 | +52.4% | 290,256 | +21.9% | 0.00% | – |
| Q4 2016 | $3,668,000 | +43.9% | 238,092 | +21.5% | 0.00% | – |
| Q3 2016 | $2,549,000 | +14.0% | 195,975 | +22.0% | 0.00% | – |
| Q2 2016 | $2,235,000 | -8.1% | 160,691 | +0.3% | 0.00% | – |
| Q1 2016 | $2,432,000 | -12.0% | 160,205 | +10.0% | 0.00% | – |
| Q4 2015 | $2,765,000 | +4.5% | 145,605 | +4.6% | 0.00% | – |
| Q3 2015 | $2,645,000 | -2.7% | 139,165 | +31.9% | 0.00% | – |
| Q2 2015 | $2,718,000 | – | 105,534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|